Engineering guide RNA to reduce the off-target effects of CRISPR.


Journal

Journal of genetics and genomics = Yi chuan xue bao
ISSN: 1673-8527
Titre abrégé: J Genet Genomics
Pays: China
ID NLM: 101304616

Informations de publication

Date de publication:
20 11 2019
Historique:
received: 18 08 2019
revised: 05 11 2019
accepted: 15 11 2019
pubmed: 7 1 2020
medline: 21 7 2020
entrez: 7 1 2020
Statut: ppublish

Résumé

As versatile and robust genome editing tools, clustered regularly interspaced short palindromic repeats (CRISPR) technologies have been broadly used in basic research, biotechnology, and therapeutic development. Off-target mutagenesis by CRISPR systems has been demonstrated, and various methods have been developed to markedly increase their specificity. In this review, we highlight the efforts of producing and modifying guide RNA (gRNA) to minimize off-target activities, including sequence and structure design, tuning expression and chemical modification. The modalities of gRNA engineering can be applied across CRISPR systems. In conjunction with CRISPR protein effectors, the engineered gRNA enables efficient and precise genome editing.

Identifiants

pubmed: 31902584
pii: S1673-8527(19)30176-6
doi: 10.1016/j.jgg.2019.11.003
pii:
doi:

Substances chimiques

RNA, Guide 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

523-529

Informations de copyright

Copyright © 2019 Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Ltd. All rights reserved.

Auteurs

Jing Wu (J)

Department of Pathology, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China; Frontier Science Center for Immunology and Metabolism, Wuhan University, 430071, China.

Hao Yin (H)

Department of Pathology, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China; Frontier Science Center for Immunology and Metabolism, Wuhan University, 430071, China; Department of Urology, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: haoyin@whu.edu.cn.

Articles similaires

Prader-Willi Syndrome Humans Angelman Syndrome CRISPR-Cas Systems Human Embryonic Stem Cells
Gene Editing Climate Change Africa South of the Sahara Crops, Agricultural Agriculture
Animals Humans CRISPR-Cas Systems Mice Vascular Endothelial Growth Factor A
Animals CRISPR-Cas Systems Gene Editing Animals, Genetically Modified Livestock

Classifications MeSH